Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

MedShape

Explore full profile

Medical device company developing and marketing soft tissue fixation and fracture management devices

Atlanta, United StatesFounded 2005Biotech & Life Sciences
Valuation <$5M Last recorded · 2014
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for MedShape and the history behind them.

About MedShape

MedShape, Inc. operates as an orthopedic medical device company, concentrating on the development and manufacturing of surgical solutions for the foot and ankle market. Founded in 2005 by Dr. Ken Gall, Douglas Pacaccio, and Jeff Tyber, the company was born from research conducted at the Georgia Institute of Technology's VentureLab. The founders, including CEO Kurt Jacobus who joined in 2006, shared a background in mechanical engineering from the University of Illinois and a vision to apply advanced material science to solve challenges in orthopedic surgery.

The company's core business revolves around its proprietary shape memory technologies, specifically using superelastic nickel-titanium (NiTiNOL) alloys and shape memory polymers. This technology allows for the creation of orthopedic implants that can change shape inside the body. The devices are designed to be inserted in a compact form during surgery and then deploy into a permanent, secure geometry, adapting to the surgical site to maintain fixation and compression during the healing process. This active response to the body’s changes, such as bone resorption, distinguishes its products from traditional static implants. MedShape's clients are primarily orthopedic surgeons specializing in foot and ankle procedures. Revenue is generated through the sale of these specialized medical devices. In April 2021, the company was acquired by DJO, a subsidiary of Colfax Corporation, integrating MedShape's portfolio into DJO's expanding foot and ankle business.

MedShape's product portfolio includes devices for fracture fixation, joint fusion, and soft tissue injury repair. A notable product is the DynaNail® TTC Fusion System, launched in 2011, an intramedullary nail that uses NiTiNOL to maintain compression for treating severe hindfoot deformities and arthritis. Another key product line, the DynaClip Bone Fixation System, consists of superelastic NiTiNOL staples that provide continuous compression for fusions. The company also developed the Morphix® Suture Anchor, made from a shape-memory polymer, which deploys expanding wings to secure soft tissue to bone without relying on traditional screw threads. MedShape was also a pioneer in using 3-D printing to create FDA-cleared titanium alloy orthopedic devices, allowing for patient-specific designs and complex geometries.

Source: Dealroom company data

At a glance

Founded
2005
Headquarters
Atlanta, United States
Sector
Biotech & Life Sciences

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • US National Science Foundation

Series A1 investor entered at this stage

Series B and later1 investor entered at this stage

  • GE Capital
Team profiled 9 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about MedShape on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See MedShape on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.